Founded in 2019, Munich-based Virtonomy provides a cloud platform that creates realistic digital patient twins using extensive datasets and multiphysics simulations. These virtual patients allow med-tech companies to test devices faster, run population analyses, and perform complete virtual studies, cutting development time by up to 40 % and saving millions in costs. The technology is already used by global leaders such as Medtronic, Johnson & Johnson, and Boston Scientific. With its recent Series A funding of more than €5 million, the company plans to deepen regulatory integration so virtual studies can be accepted in approval processes. The fresh capital will also support international scaling, a stronger global presence, and team expansion. Bayern Kapital has backed the company since its 2021 seed round, underscoring continued investor confidence in Virtonomy’s growth prospects.

Total raised

$6M

Funding rounds

2

Latest round

Series A

Latest activity

Dec 2025